Skip to content
Unrated Drug recall · FDA · Published September 9, 2013

Timolol Maleate Sterile Ophthalmic Solution

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

🇺🇸 FDA recall #D-1073-2014DrugPACK Pharmaceuticals, LLC ›
Take action

Contact the company

Recalling firmPACK Pharmaceuticals, LLC1110 W Lake Cook Rd, Ste 301 · Buffalo Grove, IL 60089-1944
Write-up in progress

We’re still writing up this recall

We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.

Source Page by GovInfoNow · govinfonow.com/recall/46618-pack-pharmaceuticals-llc-recalls-timolol-maleate-sterile-ophthalmic-solution-usp · Recall date September 9, 2013 · FDA enforcement record: FDA #D-1073-2014

Cite this page

“Timolol Maleate Sterile Ophthalmic Solution.” GovInfoNow, recall dated September 9, 2013. https://govinfonow.com/recall/46618-pack-pharmaceuticals-llc-recalls-timolol-maleate-sterile-ophthalmic-solution-usp. Based on FDA recall #D-1073-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1073-2014%22&limit=1).

How to tell if you have this one

  • Brand
    PACK Pharmaceuticals, LLC
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico.
Recall numberProduct, codes & lotsQuantity
D-1068-2014Ofloxacin Ophthalmic Solution, USP 0.3%, 5mL, (NDC 16571-130-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #:OW3061,OW3062. Exp. 05/15.32,029 bottles
D-1069-2014Ofloxacin Ophthalmic Solution, USP 0.3%, 10mL, (NDC 16571-130-11). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #:OW3071.Exp. 06/2015.126 bottles
D-1070-2014Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 5mL, (NDC 16571-140-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #: NW3061,NW3062. Exp. 05/15.3,415 bottles
D-1071-2014Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 10mL, (NDC 16571-140-10). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #:NW3071. Exp. 06/15.78 bottles
D-1072-2014Timolol Maleate Sterile Ophthalmic Solution, USP 0.5%, 5mL, (NDC 16571-141-50). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #:NDW3065,NDW3066,NDW3067,NDW3068,NDW3069. Exp.05/15.122,551 bottles
D-1073-2014Timolol Maleate Sterile Ophthalmic Solution, USP 0.5%, 10mL, (NDC 16571-141-10). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.; Lot #:NDW3071,NDW3072. Exp.06/152,022 bottles

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Sep 9, 201312. FDA classified it Class III: Feb 4, 201423. Published in FDA’s Enforcement Report: Feb 12, 201434. FDA terminated the recall: Apr 11, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1073-2014 (September 9, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1073-2014 to see it in context.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA